| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |